CN105918946A - 一种枣杞养肝组合物、颗粒剂及其制备方法 - Google Patents
一种枣杞养肝组合物、颗粒剂及其制备方法 Download PDFInfo
- Publication number
- CN105918946A CN105918946A CN201610270086.9A CN201610270086A CN105918946A CN 105918946 A CN105918946 A CN 105918946A CN 201610270086 A CN201610270086 A CN 201610270086A CN 105918946 A CN105918946 A CN 105918946A
- Authority
- CN
- China
- Prior art keywords
- fructus
- parts
- liver
- herba
- fructus jujubae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 76
- 239000008187 granular material Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 title abstract description 12
- 244000241872 Lycium chinense Species 0.000 title abstract 3
- 235000015468 Lycium chinense Nutrition 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 26
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 24
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 24
- 240000008042 Zea mays Species 0.000 claims abstract description 24
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 24
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 24
- 235000005822 corn Nutrition 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 241000244938 Penthorum chinense Species 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 7
- 238000001125 extrusion Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 231100000753 hepatic injury Toxicity 0.000 abstract description 27
- 239000003814 drug Substances 0.000 abstract description 20
- 206010067125 Liver injury Diseases 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 abstract 1
- 206010072268 Drug-induced liver injury Diseases 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 239000005017 polysaccharide Substances 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 230000003908 liver function Effects 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 6
- 108010082126 Alanine transaminase Proteins 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 6
- -1 Stepharine Chemical class 0.000 description 6
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 230000002443 hepatoprotective effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 235000018553 tannin Nutrition 0.000 description 5
- 229920001864 tannin Polymers 0.000 description 5
- 239000001648 tannin Substances 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 240000006079 Schisandra chinensis Species 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011812 mixed powder Substances 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001007 puffing effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- PLQMEXSCSAIXGB-SAXRGWBVSA-N (+)-artemisinic acid Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(=C)C(O)=O)[C@H]21 PLQMEXSCSAIXGB-SAXRGWBVSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 235000003069 Artemisia scoparia Nutrition 0.000 description 2
- 241001249148 Artemisia scoparia Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- WXQYRBLGGSLJHA-UHFFFAOYSA-N Capillene Chemical compound CC#CC#CCC1=CC=CC=C1 WXQYRBLGGSLJHA-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 244000111489 Gardenia augusta Species 0.000 description 2
- 235000018958 Gardenia augusta Nutrition 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 2
- TYHJMEIBGDDCPA-UHFFFAOYSA-N N-Methylpelletierine Chemical compound CN1CCCCC1CC(C)=O TYHJMEIBGDDCPA-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- JEIZLWNUBXHADF-UHFFFAOYSA-N Pelletierine Chemical compound CC(=O)CC1CCCCN1 JEIZLWNUBXHADF-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- MQSZRBPYXNEFHF-UHFFFAOYSA-N rhamnocitrin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C=C1 MQSZRBPYXNEFHF-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N α-thujene Chemical compound CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- OGJKMZVUJJYWKO-CYBMUJFWSA-N (+)-Stepharine Natural products C([C@H]1NCCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 OGJKMZVUJJYWKO-CYBMUJFWSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- PLUVLWUSXQCTNH-UHFFFAOYSA-N (2-methoxy-4-prop-2-enylphenyl) 3-methylbutanoate Chemical compound COC1=CC(CC=C)=CC=C1OC(=O)CC(C)C PLUVLWUSXQCTNH-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-VIFPVBQESA-N (R)-(+)-alpha-terpineol Chemical compound CC1=CC[C@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-VIFPVBQESA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- AKWUNZFZIXEOPV-UHFFFAOYSA-N 2-[4-[[3-[7-chloro-1-(oxan-4-ylmethyl)indol-3-yl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]acetamide Chemical compound C1CN(CC(=O)N)CCN1CC1=NC(C=2C3=CC=CC(Cl)=C3N(CC3CCOCC3)C=2)=NO1 AKWUNZFZIXEOPV-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- RANQPHKSRUUPKK-UHFFFAOYSA-N 3-O-[alpha-L-arabinofuranosyl-(1->2)-O-{beta-D-glucopyranosyl-(1->3)}-(alpha-L-arabinopyranosyl)]jujubogenin Natural products CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C33COC2(C3)O1 RANQPHKSRUUPKK-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- SLJTWDNVZKIDAU-SVAFSPIFSA-N Betulonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C SLJTWDNVZKIDAU-SVAFSPIFSA-N 0.000 description 1
- SLJTWDNVZKIDAU-CKURCAGRSA-N Betulonic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O SLJTWDNVZKIDAU-CKURCAGRSA-N 0.000 description 1
- 101100280477 Caenorhabditis elegans lbp-1 gene Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- UGWAFWFSLCHCJD-UHFFFAOYSA-N Cornuside Natural products OC1C(O)C(O)C(CO)OC1OC1C(C=C)C(CCOC(=O)C=2C=C(O)C(O)=C(O)C=2)C(C(O)=O)=CO1 UGWAFWFSLCHCJD-UHFFFAOYSA-N 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- OPUFDNZTKHPZHM-UHFFFAOYSA-N Euparin Chemical compound CC(=O)C1=C(O)C=C2OC(C(=C)C)=CC2=C1 OPUFDNZTKHPZHM-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- FWAYDNJCBHNWQD-JBWLPIRVSA-N Sarmentosin Chemical compound OC[C@H]1O[C@@H](OC\C=C(\CO)C#N)[C@H](O)[C@@H](O)[C@@H]1O FWAYDNJCBHNWQD-JBWLPIRVSA-N 0.000 description 1
- FWAYDNJCBHNWQD-AREZNJCPSA-N Sarmentosin Natural products O(C/C=C(/C#N)\CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWAYDNJCBHNWQD-AREZNJCPSA-N 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- VSJGJMKGNMDJCI-ZASXJUAOSA-N Sweroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](CCOC2=O)C2=CO1 VSJGJMKGNMDJCI-ZASXJUAOSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 241001593750 Turcica Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- OGJKMZVUJJYWKO-ZDUSSCGKSA-N ac1lh1t2 Chemical compound C([C@@H]1NCCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 OGJKMZVUJJYWKO-ZDUSSCGKSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- PLQMEXSCSAIXGB-UHFFFAOYSA-N artemisininic acid Natural products C1=C(C)CCC2C(C)CCC(C(=C)C(O)=O)C21 PLQMEXSCSAIXGB-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- NDVASEGYNIMXJL-UHFFFAOYSA-N beta-sabinene Natural products C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- GHNBEBDYYSVNEK-UHFFFAOYSA-N capillon Natural products CC=CC=CC(=O)C1=CC=CC=C1 GHNBEBDYYSVNEK-UHFFFAOYSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- BUMHLZPAQKNDBJ-JTQLQIEISA-N euparin Natural products CC=C[C@H]1Cc2cc(C(=O)C)c(O)cc2O1 BUMHLZPAQKNDBJ-JTQLQIEISA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- NZYSZZDSYIBYLC-UHFFFAOYSA-N glycycoumarin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O NZYSZZDSYIBYLC-UHFFFAOYSA-N 0.000 description 1
- NPQWZAAWZLVQIZ-UHFFFAOYSA-N glycycoumarin Natural products COc1cc2OC(=O)C(=Cc2c(O)c1CC=C(C)C)c3ccc(O)cc3O NPQWZAAWZLVQIZ-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229930192286 jujuboside Natural products 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- SMTKSCGLXONVGL-ZEIULZLQSA-N methyl (2r,3s,4r)-3-ethenyl-4-[2-(3,4,5-trihydroxybenzoyl)oxyethyl]-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2h-pyran-5-carboxylate Chemical compound O([C@H]1OC=C([C@@H]([C@@H]1C=C)CCOC(=O)C=1C=C(O)C(O)=C(O)C=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SMTKSCGLXONVGL-ZEIULZLQSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- OGJKMZVUJJYWKO-UHFFFAOYSA-N proaporphine Natural products C1=2C3=C(OC)C(OC)=CC=2CCNC1CC13C=CC(=O)C=C1 OGJKMZVUJJYWKO-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- VSJGJMKGNMDJCI-QXSNVGMTSA-N sweroside Natural products OC[C@H]1O[C@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O VSJGJMKGNMDJCI-QXSNVGMTSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种枣杞养肝组合物、颗粒剂及其制备方法,属于保健食品及加工技术领域。本发明根据中医药食同源理念,将大枣、枸杞、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草8种药食同源物品,与茵陈、垂盆草2味中药复配,对肝损伤(尤其是药物性肝损伤)具有一定的防治功效。配方中栀子、山茱萸、赶黄草、茵陈、垂盆草为主要原料,具有保肝功效,其他原料次之,具有增强机体免疫力之功效,诸原料合用能防治肝损伤,发挥保肝、护肝和强肝功效。上述药食同源物品、中药与功能性保肝因子玉米肽复配,还能协同增强其保肝、护肝和强肝功效。
Description
技术领域
本发明涉及一种枣杞养肝组合物,同时还涉及枣杞养肝颗粒剂及其制备方法,属于保健食品及加工技术领域。
背景技术
肝是人体最大的腺体,具有重要的生理功能。随着生活节奏的加快以及工作压力的增大,饮食不健康、饮酒过多等均会造成肝脏损伤,出现面黄消瘦、食欲不振、神疲气短等症状,严重困扰人们的日常生活,如不加以控制或治疗,进一步恶化将导致严重不可逆的肝损伤。近年来,我国肝损伤的发病率呈逐年上升趋势,对人体健康带来了严重损害。目前,肝损伤的治疗多须长期用药,这些药物虽疗效确切,但也具有一定的肝毒性,有些甚至会加重肝损伤。
对于肝损伤这类常见病症,临床上尚缺少效果好、毒性低的特效药,并且市场上也缺少相应的辅助治疗肝损伤的保健食品。公布号CN101015669A的发明专利公开了一种治疗亚急性重型肝炎的药物,由茵陈、栀子、黄柏、黄芩、泽泻、赤芍、丹参、郁金、白芍、枸杞子、熟地、五味子、山茱萸、地锦草、大枣、甘草、三七粉共17味原料药制成,组方重在泻火解毒、清热燥湿、利湿退黄,对亚急性重型肝炎及慢加急性重型肝炎疗效确切,但是用药过重,不良反应明显,不适于肝损伤的调理和治疗。公布号CN101455819A的发明专利公开了一种治疗慢性乙肝的营养保健品,以柴胡、白芍、白术、茯苓、甘草疏肝解郁,茵陈、白花蛇舌草、徐长卿等清热解毒、利湿通络,青皮、郁金疏肝理气,山药、菊花、桑葚、刀豆、枸杞、生地、太子参等补益肝肾、健脾和胃,组方能阻断和清除乙肝病毒,增强机体免疫力,恢复肝功,但是用药种类过多、配伍复杂,对肝损伤的疗效不确切。公布号CN1093532A的发明专利公开了一种强肝保健茶,由绿茶、五味子、乌梅、山楂、红枣、山药、白芍、郁金、板蓝根、虎杖根、枸杞、柴胡、女贞子、败酱草共14味原料药制成,能养血柔肝、强肝保肝,但是对于肝损伤的调理和养肝功效仍有待提高,且适口性较差。
发明内容
本发明的目的是提供一种枣杞养肝组合物,用于预防和治疗肝损伤,发挥保肝、护肝和强肝功效。
同时,本发明还提供一种枣杞养肝颗粒。
最后,本发明再提供一种枣杞养肝颗粒的制备方法。
为了实现以上目的,本发明所采用的技术方案是:
枣杞养肝组合物,包括以下质量份数的组分:大枣6~8份,枸杞1~2份,茵陈1~2份,栀子1~2份,垂盆草1~2份,三七1~2份,山茱萸1~2份,五味子1~2份,赶黄草1~2份,甘草1~2份。
优选的,枣杞养肝组合物还包括功能性保肝因子,以质量份数计,玉米肽0.1~0.2份。
各原料功效简述如下:
大枣:为鼠李科枣属植物枣的果实;味甘、性温,归心、脾、胃经;果实含生物碱如光千金藤碱、N-去甲基荷叶、八婆碱等,三萜酸类如白桦脂酮酸、齐墩果酸、山楂酸等,皂苷类如大枣皂苷、酸枣皂苷,甾醇类如豆甾醇、链甾醇、有谷甾醇,还含有油酸、多糖、芸香苷、维生素C、核黄素、胡萝卜素、烟酸等活性成分;大枣能补脾胃、益气血、安心神、调营卫、和药性,主治脾胃虚弱、气血不足、食少便溏、倦怠乏力、心悸失眠、营卫不和;现代药理学证明大枣具有中枢抑制、护肝、增强肌力、抗肿瘤、抗氧化及延缓衰老等作用。
枸杞:为茄科枸杞属植物宁夏枸杞的果实;味甘、性平,归肝、肾、肺经;果实含生物碱如甜菜碱、阿托品、天仙子胺、丙烯胺类,多糖如糖肽、多糖LBP-1、LLBP等,还含有脑苷脂、熊果酸、玉蜀黍黄质、酸浆果红素、隐黄质、胡萝卜素、核黄素、烟酸、维生素C等,以及钾、钙、钠、锌、铁、铜、锰、硒、铬、锶等元素;枸杞能养肝、滋肾、润肺,主治肝肾亏虚、头晕目眩、目视不清、腰膝酸软、虚劳咳嗽、消渴引饮;现代药理学证明枸杞具有延缓衰老、抑菌、降血糖血压、抗肿瘤、降血脂、保肝及抗脂肪肝等作用。
茵陈:为菊科蒿属植物猪毛蒿或茵陈蒿的地上部分;味微苦、微辛,性微寒,归脾、胃、膀胱经;猪毛蒿全草含挥发油,以单萜为主,主要成分有丁香油酚、丁香油酚戊酸酯、丁香油酚异戊酸酯、桉叶素、柠檬烯等,酚酸类成分如咖啡酸、6,7-二甲氧基桂皮酸、绿原酸等,还含有槲皮素-3-O-β-D-葡萄糖苷、大黄素等,花蕾、花和果实含香豆素类如蒿属香豆素、异泽兰素等;茵陈蒿地上部分含挥发油,萜类如柠檬烯、月桂烯、对聚伞花素等,苯乙炔、双亚乙基类成分如茵陈二炔、茵陈烯酮、茵陈炔醇等,脂肪酸如棕榈酸、硬脂酸、亚油酸、油酸等,黄酮类成分如鼠李柠檬素、茵陈蒿黄酮、异茵陈蒿黄酮等,还含有茵陈蒿酸、3,5-二甲氧基烯丙苯等活性成分;茵陈能清热利湿、退黄,主治黄疸、小便不利、湿疮瘙痒;现代药理学证明茵陈具有利胆、保肝、解热镇痛消炎、抗病原微生物、抗肿瘤等作用。
栀子:为茜草科栀子属植物栀子的果实;味苦、性寒,归心、肝、肺、胃、三焦经;果实含环烯醚萜类成分如栀子苷、山栀苷、栀子酮苷、鸡屎藤次苷甲酯等,酚酸类成分如绿原酸、3,4-二-O-咖啡酰基奎宁酸等,还含有类胡萝卜素、藏红花素、藏红花酸、藏红花素葡萄糖苷、芸香苷、熊果酸、多糖等活性成分;栀子能泻火除烦、清热利湿、凉血解毒,主治热病心烦、肝火目赤、头痛、湿热黄疸、吐血衄血、口舌生疮、疮疡肿毒、扭伤肿痛;现代药理学证明栀子对消化系统(如肝功、胆汁分泌、胰腺及胃功能)、心血管系统产生作用,还能抗菌、抗炎、抗肿瘤等。
垂盆草:为景天科景天属植物垂盆草的全草;味甘、淡、微酸,性凉,归肝、肺、大肠经;全草含消旋甲基异石榴皮碱、二氢异石榴皮碱、垂盆草苷、β-谷甾醇、甘露醇、氨基酸等活性成分;垂盆草能清热解毒、利湿,主治湿热黄疸、咽喉肿痛、痢疾、水火烫伤、湿疹;现代药理学证明垂盆草具有护肝、抗病毒、抗氧化、免疫抑制等作用。
三七:为五加科人参属植物三七的根;味甘、微苦,性温,归肝、胃、心、大肠经;根主含达玛烷型四环三萜类成分如人参皂苷、三七皂苷、绞股蓝苷等,还含有三七素、β-谷甾醇、三七糖苷,以及氨基酸类成分(如田七氨酸、天冬氨酸)、多炔成分(如人参炔三醇)、黄酮类成分(如槲皮素及其苷)、多糖类成分(如三七多糖)等活性成分;三七能止血散瘀、消肿定痛,主治吐血咳血尿血便血、跌扑损伤、胸痹心痛、脘胁久痛、癥瘕积块、疮痈肿痛;现代药理学证明三七能抗凝血、保护脊髓损伤,同时对心血管系统、肾组织、脑组织和神经产生影响。
山茱萸:为山茱萸科山茱萸属植物山茱萸的果肉;味酸、性微温,归肝、肾经;果肉含鞣质成分如山茱萸鞣质、丁子香鞣质、路边青鞣质、喜树鞣质、没食子酸等,糖苷成分如山茱萸裂苷、莫罗忍冬苷、马钱子苷、当药苷、山茱萸苷等,还含有顺-四氢呋喃-2,5-二羧酸二甲基酯、7-O-没食子酰-D-景天庚酮糖等活性成分;山茱萸能补益肝肾、收敛固脱,主治头晕目眩、耳聋耳鸣、腰膝酸软、虚汗不止;现代药理学证明山茱萸具有抗炎、抗心律失常、抑制血小板聚集等作用,同时对免疫系统、血糖、心功能等产生影响。
五味子:为五味子科五味子属植物五味子或华中五味子的果实;味酸、性温,归肺、心、肾经;五味子果实含木脂素如戈米辛、五味子素、红楠树脂素等,以及挥发油如α及β-蒎烯、α-侧柏烯、α-松油烯醇等活性成分;华中五味子果实含木脂素如右旋-表加巴辛、外消旋-安五脂素、华中五味子酮、华中五味子脂等,还含有安五味子酸、五味子异醇等活性成分;五味子能收敛固涩、益气生津、宁心安神,主治久咳虚喘、久泻不止、自汗盗汗、津伤口渴、心悸失眠;现代药理学证明五味子对中枢神经系统、呼吸系统、心血管系统、代谢、肝脏等产生作用,还具有抗氧化、抗溃疡、抗癌、抗肾病变等作用。
赶黄草(水泽兰):为虎耳草科扯根菜属植物扯根菜的全草;味苦、微辛,寒;全草含有黄酮类如槲皮素、槲皮素-3-α-L-吡喃鼠李糖苷、生松黄烷酮-7-β-O-D-吡喃葡萄糖苷,还含有没食子酸、2,6-二羟基苯乙酮-4-O-β-D-吡喃葡萄糖苷、β-谷甾醇等活性成分;赶黄草能利水除湿、活血散瘀、止血、解毒,主治水肿、小便不利、黄疸、痢疾、跌打损伤、疮痈肿毒;现代药理学证明赶黄草具有保肝、利胆等作用。
甘草:为豆科甘草属植物甘草、光果甘草、胀果甘草的根及根茎;味甘、性平,归脾、胃、心、肺经;甘草的根及根茎主含三萜皂苷,主要为甘草甜素,其他如乌拉尔甘草皂苷、甘草皂苷等,香豆素类化合物如甘草香豆素、甘草酚、异甘草酚、甘草香豆素-7-甲醚、新甘草酚等,还含有生物碱类、喹啉类、异喹啉类、多糖(如甘草葡聚糖、甘草多糖、β-D-葡聚糖)等活性成分;光果甘草、胀果甘草的化学成分参见中药大辞典;甘草能和中缓急、润肺、解毒、调和诸药,灸用治脾胃虚弱、倦怠食少、腹痛便溏、四肢挛急疼痛、心悸、脏躁、肺痿咳嗽,生用治咽喉肿痛、痈疮肿毒、小儿胎毒及药物、食物中毒;现代药理学证明甘草具有抗微生物、保肝、抗炎镇咳祛痰、抗肿瘤、抗突变、抗氧化等作用,对心血管系统、免疫系统、生殖系统以及脑、肾功能等产生影响。
玉米肽:对四氯化碳和硫代乙酰胺引起的实验性肝损伤小鼠血清中谷丙转氨酶的升高有明显的降低作用,同时能降低丙二醛含量并增加肝糖原含量,可通过抑制肝细胞脂质过氧化反应稳定生物膜,使肝细胞变性或坏死减轻,迅速恢复肝细胞功能(孙红等,玉米肽对动物实验性肝损伤的保护作用[J],中药药理与临床,2002)。
枣杞养肝颗粒剂,以质量份数计,原料包括:大枣6~8份,枸杞1~2份,茵陈1~2份,栀子1~2份,垂盆草1~2份,三七1~2份,山茱萸1~2份,五味子1~2份,赶黄草1~2份,甘草1~2份。
优选的,枣杞养肝颗粒剂的原料还包括功能性保肝因子,以质量份数计,玉米肽0.1~0.2份。
枣杞养肝颗粒剂的制备方法,包括以下步骤:
1)按照质量份数准确取各原料,大枣、枸杞为一组,茵陈、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草为一组,分别用乙醇溶液提取,过滤,合并两组提取液,浓缩、喷雾干燥,得到粉末A;
2)取大枣、枸杞组提取后的残渣,干燥、挤压膨化、粉碎,得到粉末B;
3)将粉末A、粉末B、玉米肽与水混合,制粒、干燥,得到颗粒剂。
步骤1)中乙醇溶液的浓度均为50%~80%,加量均为混合物质量的3~10倍。
步骤1)中提取的温度为30~75℃,时间2~5小时。
步骤1)中浓缩可采用真空浓缩技术,浓缩至相对密度1.12~1.15即可。
步骤1)中喷雾干燥的工艺参数为:进风温度180~220℃,出风温度90~120℃。
步骤2)中干燥可采用真空干燥(温度50~80℃)或热风干燥,干燥至水分含量8%~15%。
步骤2)中挤压膨化可采用双螺杆挤压膨化机,主机频率30~40Hz,挤压温度170~190℃。
步骤2)中粉碎可采用超微粉碎技术,粉碎至500~600目即可。
步骤3)中水的加量为使混合物水分含量达30%~65%。
步骤3)中干燥至水分含量小于5%即可。
本发明的有益效果:
本发明根据中医药食同源理念,将大枣、枸杞、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草8种药食同源物品,与茵陈、垂盆草2味中药复配,对肝损伤(尤其是药物性肝损伤)具有一定的防治功效。配方中栀子、山茱萸、赶黄草、茵陈、垂盆草为主要原料,具有保肝功效,其他原料次之,具有增强机体免疫力之功效,诸原料合用能防治肝损伤,发挥保肝、护肝和强肝功效。上述药食同源物品、中药与功能性保肝因子玉米肽复配,还能协同增强其保肝、护肝和强肝功效。
本发明在制备枸杞养肝颗粒剂时,利用大枣、枸杞富含多糖、膳食纤维的特点,将大枣、枸杞提取后的残渣挤压膨化并超微粉碎,一方面降低残渣粉的粗糙度,另一方面直接将该超微粉用作造粒赋形剂,不再添加蔗糖、糊精等辅料。这种针对原料的搭配和重组方式,不仅能改善原料中膳食纤维和多糖特性,赋予产品新的特性,还能对提取残渣进行回收利用,更加安全环保。
本发明中枸杞养肝颗粒剂的制备工艺简单、操作简便,适于大规模生产及应用,且颗粒剂携带方便,冲泡简单。
具体实施方式
下述实施例仅对本发明作进一步详细说明,但不构成对本发明的任何限制。
实施例1
枣杞养肝组合物,由以下质量份数的组分组成:大枣6份,枸杞2份,茵陈1份,栀子2份,垂盆草1份,三七2份,山茱萸1份,五味子2份,赶黄草1份,甘草2份。
实施例2
枣杞养肝组合物,由以下质量份数的组分组成:大枣7份,枸杞1份,茵陈2份,栀子1.5份,垂盆草2份,三七1.5份,山茱萸2份,五味子1份,赶黄草2份,甘草1份,玉米肽0.1份。
实施例3
枣杞养肝组合物,由以下质量份数的组分组成:大枣8份,枸杞1.5份,茵陈1.5份,栀子1份,垂盆草1.5份,三七1份,山茱萸1.5份,五味子1.5份,赶黄草1.5份,甘草1.5份,玉米肽0.2份。
实施例4
枣杞养肝颗粒剂,以质量份数计,原料包括:大枣8份,枸杞2份,茵陈2份,栀子1份,垂盆草2份,三七1份,山茱萸2份,五味子1份,赶黄草2份,甘草1份,玉米肽0.15份。制备步骤如下:
1)按照质量份数准确取各原料,大枣、枸杞为一组,茵陈、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草为一组,分别加入5倍量浓度65%的乙醇溶液,在温度50℃下提取2.5小时,过滤,合并两组提取液,真空浓缩至相对密度1.12,喷雾干燥(进风温度200℃,出风温度100℃),得粉末A备用;
2)取大枣、枸杞组提取后的残渣,在温度60℃下真空干燥至水分含量为10%,用双螺杆挤压膨化机挤压,主机频率30Hz,挤压温度180℃,挤压后超微粉碎至500目,得粉末B备用;
3)将粉末A、粉末B和玉米肽混合,在混合粉末中加水至水分含量达45%,用造粒机造粒,所得颗粒真空干燥至水分含量小于5%,包装,即得枣杞养肝颗粒剂。
实施例5
枣杞养肝颗粒剂,以质量份数计,原料包括:大枣7份,枸杞1.5份,茵陈1.5份,栀子1.5份,垂盆草1.5份,三七1.5份,山茱萸1.5份,五味子1.5份,赶黄草1.5份,甘草1.5份,玉米肽0.1份。制备步骤如下:
1)按照质量份数准确取各原料,大枣、枸杞为一组,茵陈、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草为一组,分别加入10倍量浓度50%的乙醇溶液,在温度30℃下提取5小时,过滤,合并两组提取液,真空浓缩至相对密度1.15,喷雾干燥(进风温度180℃,出风温度90℃),得粉末A备用;
2)取大枣、枸杞组提取后的残渣,在温度50℃下真空干燥至水分含量为8%,用双螺杆挤压膨化机挤压,主机频率40Hz,挤压温度170℃,挤压后超微粉碎至600目,得粉末B备用;
3)将粉末A、粉末B和玉米肽混合,在混合粉末中加水至水分含量达60%,用造粒机造粒,所得颗粒真空干燥至水分含量小于5%,包装,即得枣杞养肝颗粒剂。
实施例6
枣杞养肝颗粒剂,以质量份数计,原料包括:大枣6份,枸杞1份,茵陈1份,栀子2份,垂盆草1份,三七2份,山茱萸1份,五味子2份,赶黄草1份,甘草2份,玉米肽0.2份。制备步骤如下:
1)按照质量份数准确取各原料,大枣、枸杞为一组,茵陈、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草为一组,分别加入3倍量浓度80%的乙醇溶液,在温度75℃下提取2小时,过滤,合并两组提取液,真空浓缩至相对密度1.13,喷雾干燥(进风温度220℃,出风温度120℃),得粉末A备用;
2)取大枣、枸杞组提取后的残渣,在温度80℃下热风干燥至水分含量为15%,用双螺杆挤压膨化机挤压,主机频率40Hz,挤压温度190℃,挤压后超微粉碎至500目,得粉末B备用;
3)将粉末A、粉末B和玉米肽混合,在混合粉末中加水至水分含量达35%,用造粒机造粒,所得颗粒沸腾干燥至水分含量小于5%,包装,即得枣杞养肝颗粒剂。
试验例
1、枣杞养肝颗粒剂对化学性肝损伤的保护作用
试验方法:取昆明种健康小鼠,雌雄各半,体重20±2g;将小鼠随机分为对照组(正常喂养)、模型组(四氯化碳造模,肝损伤)、玉米肽(20mhg/kg小鼠体重)组、实施例5中枣杞养肝颗粒剂高、中、低剂量组,每组10只;对照组和模型组小鼠均给予生理盐水(10mL/kg小鼠体重),玉米肽组和枣杞养肝颗粒剂高(40mg/kg小鼠体重)、中(20mg/kg小鼠体重)、低剂量(10mg/kg小鼠体重)组分别给予相应的药液。小鼠于首日上、下午和次日下午各灌胃给药1次,以后每天给药1次,连续7天。末次给药后小鼠禁食不禁水4h,除对照组外其余各组分别口服0.1%CCl4 0.2mL/10g,禁食,24h后断头处死小鼠。取血分离血清,按赖氏法测定血清丙氨酸氨基转移酶(ALT)活性;另取肝脏,用冷生理盐水冲洗后制成10%的肝匀浆,按硫代巴比妥酸(TBA)比色法测定丙二醛(MDA)含量,黄嘌呤氧化酶法测定超氧化物歧化酶(SOD)活性,结果见下表1。
表1枣杞养肝颗粒剂对肝损伤小鼠血清ALT活性、肝脏MDA含量和SOD活性的影响
组别(x±s,n=10) | ALT(U/L) | SOD(NU/mL) | MDA(nmol/mL) |
对照组 | 39.4±1.6 | 24.8±4.05 | 154.9±2.58 |
模型组 | 176.1±18.5a | 35.1±2.98a | 108.9±3.8a |
玉米肽组 | 155.7±28.3* | 31.3±8.01* | 141.2±1.42* |
低剂量组 | 154.7±29.1* | 30.1±8.09* | 140.7±1.65* |
中剂量组 | 113.3±18.1**bb | 26.4±5.71**bb | 157.6±4.82*bb |
高剂量组 | 101.5±18.2**bb | 25.3±6.72**bb | 168.1±4.9**bb |
注:与模型组相比,*P<0.05,**P<0.01;与对照组相比,a P<0.05;与玉米肽组相比,bb P<0.01。
从表1可以看出,与对照组相比,模型组小鼠血清ALT活性明显升高,给予玉米肽或枣杞养肝颗粒剂可明显抑制血清ALT水平的升高。试验还显示CCl4损伤后,小鼠肝匀浆MDA含量明显升高,SOD活性明显降低,而给予玉米肽或枣杞养肝颗粒剂后小鼠肝匀浆MDA含量明显降低,SOD活性明显升高。表明玉米肽和枣杞养肝颗粒剂具有较强的抗氧化作用,能增加肝细胞抗损伤能力,增加膜结构的稳定性,对肝脏有一定的保护作用。并且,与玉米肽组相比,枣杞养肝颗粒剂中、高剂量组对肝损伤具有更强的预防作用。
2、枣杞养肝颗粒剂对药物性肝损伤的治疗作用
试验对象:某医院住院治疗的药物性肝损伤60例(均符合药物性肝损伤诊断标准),随机分为治疗组和对照组,每组30例。其中,治疗组男、女各15例,年龄20~45岁,平均年龄31岁;对照组男、女各15例,年里22~46岁,平均年龄31.5岁;两组性别、年龄比较差异无统计学意义(P>0.05),具有可比性。
试验方法:对照组、治疗组均停用致肝损伤药物,对照组给予还原型谷胱甘肽(20mg/kg,购自重庆药友制药有限责任公司公司),治疗组给予还原型谷胱甘肽(20mg/kg,购自重庆药友制药有限责任公司公司)和枣杞养肝颗粒剂(0.25g/kg),每天分3次冲服,两组均治疗2周。观察服用前、后临床症状和体征改善情况,结果见下表2。
疗效判定标准为:
显效:肝功能正常,临床症状及体征消失;
有效:肝功能恢复>50%,临床症状及体征消失;
无效:肝功能恢复<50%,临床症状及体征未消失。
表2枣杞养肝颗粒剂对药物性肝损伤的治疗效果
组别 | 显效/例 | 有效/例 | 无效/例 | 总有效率(%) |
治疗组 | 12 | 12 | 6 | 80% |
对照组 | 4 | 8 | 18 | 40% |
从表2可以看出,在服用还原型谷胱甘肽的基础上增服枣杞养肝颗粒剂,治疗总有效率达80%,显著高于对照组(P<0.01),表明枣杞养肝颗粒剂对药物性肝损伤有一定的治疗效果。
Claims (10)
1.枣杞养肝组合物,其特征在于:包括以下质量份数的组分:大枣6~8份,枸杞1~2份,茵陈1~2份,栀子1~2份,垂盆草1~2份,三七1~2份,山茱萸1~2份,五味子1~2份,赶黄草1~2份,甘草1~2份。
2.根据权利要求1所述的组合物,其特征在于:还包括玉米肽0.1~0.2份。
3.枣杞养肝颗粒剂,其特征在于:以质量份数计,原料包括:大枣6~8份,枸杞1~2份,茵陈1~2份,栀子1~2份,垂盆草1~2份,三七1~2份,山茱萸1~2份,五味子1~2份,赶黄草1~2份,甘草1~2份。
4.根据权利要求3所述的颗粒剂,其特征在于:还包括玉米肽0.1~0.2份。
5.如权利要求4所述枣杞养肝颗粒剂的制备方法,其特征在于:包括以下步骤:
1)按照质量份数准确取各原料,大枣、枸杞为一组,茵陈、栀子、垂盆草、三七、山茱萸、五味子、赶黄草、甘草为一组,分别用乙醇溶液提取,过滤,合并两组提取液,浓缩、喷雾干燥,得到粉末A;
2)取大枣、枸杞组提取后的残渣,干燥、挤压、粉碎,得到粉末B;
3)将粉末A、粉末B、玉米肽与水混合,制粒、干燥,得到颗粒剂。
6.根据权利要求5所述的制备方法,其特征在于:步骤1)中乙醇溶液的浓度均为50%~80%,加量均为混合物质量的3~10倍。
7.根据权利要求6所述的制备方法,其特征在于:步骤1)中提取的温度为30~75℃,时间2~5小时。
8.根据权利要求5所述的制备方法,其特征在于:步骤1)中喷雾干燥的工艺参数为:进风温度180~220℃,出风温度90~120℃。
9.根据权利要求5所述的制备方法,其特征在于:步骤2)中挤压采用双螺杆挤压膨化机,主机频率30~40Hz,挤压温度170~190℃。
10.根据权利要求5所述的制备方法,其特征在于:步骤3)中水的加量为使混合物水分含量达30%~65%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610270086.9A CN105918946B (zh) | 2016-04-27 | 2016-04-27 | 一种枣杞养肝组合物、颗粒剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610270086.9A CN105918946B (zh) | 2016-04-27 | 2016-04-27 | 一种枣杞养肝组合物、颗粒剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105918946A true CN105918946A (zh) | 2016-09-07 |
CN105918946B CN105918946B (zh) | 2019-12-31 |
Family
ID=56837317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610270086.9A Active CN105918946B (zh) | 2016-04-27 | 2016-04-27 | 一种枣杞养肝组合物、颗粒剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105918946B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107950946A (zh) * | 2017-11-30 | 2018-04-24 | 漯河医学高等专科学校 | 一种即食甘草休闲食品及其制备方法 |
CN108112884A (zh) * | 2017-11-30 | 2018-06-05 | 慈中华 | 护肝的营养组合物及其制备方法 |
CN109287951A (zh) * | 2018-10-27 | 2019-02-01 | 湖北民族学院 | 一种含有赶黄草的解酒煮粥米 |
CN112587584A (zh) * | 2021-01-27 | 2021-04-02 | 昆明理工大学 | 一种三七复方组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822377A (zh) * | 2010-05-26 | 2010-09-08 | 好想你枣业股份有限公司 | 一种枣果保健食品及其加工方法 |
CN102048212A (zh) * | 2010-11-30 | 2011-05-11 | 安徽师范大学 | 一种保肝护肝饮料及其制备方法 |
CN105311208A (zh) * | 2015-11-28 | 2016-02-10 | 史克勇 | 一种用于护肝的中药组合物 |
-
2016
- 2016-04-27 CN CN201610270086.9A patent/CN105918946B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822377A (zh) * | 2010-05-26 | 2010-09-08 | 好想你枣业股份有限公司 | 一种枣果保健食品及其加工方法 |
CN102048212A (zh) * | 2010-11-30 | 2011-05-11 | 安徽师范大学 | 一种保肝护肝饮料及其制备方法 |
CN105311208A (zh) * | 2015-11-28 | 2016-02-10 | 史克勇 | 一种用于护肝的中药组合物 |
Non-Patent Citations (1)
Title |
---|
张伯礼等主编: "《中药不良反应与合理用药》", 30 June 2007, 清华大学出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107950946A (zh) * | 2017-11-30 | 2018-04-24 | 漯河医学高等专科学校 | 一种即食甘草休闲食品及其制备方法 |
CN108112884A (zh) * | 2017-11-30 | 2018-06-05 | 慈中华 | 护肝的营养组合物及其制备方法 |
CN107950946B (zh) * | 2017-11-30 | 2020-11-03 | 漯河医学高等专科学校 | 一种即食甘草休闲食品及其制备方法 |
CN109287951A (zh) * | 2018-10-27 | 2019-02-01 | 湖北民族学院 | 一种含有赶黄草的解酒煮粥米 |
CN112587584A (zh) * | 2021-01-27 | 2021-04-02 | 昆明理工大学 | 一种三七复方组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105918946B (zh) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104083727A (zh) | 一种养肝护肝中药组合物 | |
CN101502588B (zh) | 一种美容祛痘组合物及其制备方法 | |
CN103961521A (zh) | 一种用于治疗再生障碍性血液病的中药组合物及制备方法 | |
CN105918946A (zh) | 一种枣杞养肝组合物、颗粒剂及其制备方法 | |
CN104984297A (zh) | 一种药物组合物在制备治疗闭经药物中的用途 | |
CN103301413A (zh) | 一种治疗高血脂合并高血糖症的中药组合物 | |
CN101926942A (zh) | 一种降糖保健药茶及其制备方法 | |
CN102302673B (zh) | 一种预防和治疗糖尿病肾病的中药复方制剂 | |
CN106072656A (zh) | 一种无添加剂预防及缓解痛经的健康食品及其生产方法 | |
CN104958536A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN102370883A (zh) | 治疗心血不足神志不宁的中草药 | |
CN105395842A (zh) | 一种用于治疗糖尿病的中药组合物、口服制剂及其制备方法 | |
CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN101954022B (zh) | 一种用于治疗肺癌的中药组合物 | |
CN101167872B (zh) | 一种用于美容养颜的药物组合物及其制备方法 | |
CN113797294A (zh) | 一种治疗萎缩性胃炎的药物组合物及制备方法 | |
CN105876713A (zh) | 一种养血美容富硒胡萝卜龟苓膏及其制备方法 | |
CN105169338A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN105362630A (zh) | 一种治疗更年期综合症的药物组合物及其制备方法 | |
CN104606483A (zh) | 一种治疗体虚的中药组合物及其制备方法 | |
CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
CN103735713B (zh) | 一种改善营养性贫血的中药组合物及其制备方法 | |
CN105194296A (zh) | 一种治疗心脏疾病的药物组合物 | |
CN105362933A (zh) | 一种含有艾叶的药物组合物在制备治疗闭经药物中的用途 | |
CN104784547A (zh) | 对放疗具有增效作用的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 451162 Henan city of Zhengzhou province Xinzheng city Xuedian Applicant after: I miss you, health food, Limited by Share Ltd Address before: 451161 Meng Zhuang Town, Zhengzhou, Xinzheng, Henan Applicant before: Haoxiangni Jujube Industry Co., Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |